Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

57%

4 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 4

3(50.0%)

N/A

2(33.3%)

Phase 3

1(16.7%)

6Total

Phase 4(3)

N/A(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01208662Phase 3Active Not Recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Role: collaborator

NCT02121132Completed

Pediatric Obesity Weight Evaluation Registry (POWER) Study

Role: collaborator

NCT03541031Not ApplicableUnknown

Micronutrients as Adjunctive Treatment for Bipolar Disorder

Role: lead

NCT01804075Phase 4Completed

Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal

Role: lead

NCT02374398Phase 4Completed

Clinical Trial Comparing Tranexamic Acid (TXA) With Aquamantys Sealer in Total Knee Arthroplasty (TKA)

Role: lead

NCT02106481Not ApplicableCompleted

Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery

Role: lead

NCT01723722Phase 4Completed

Treatment of Neonatal Abstinence Syndrome

Role: lead

All 7 trials loaded